ABOUT THIS FUND
The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.
PRICE
$18.81 ▲ UP 48.35% (+$73.38)—
No price history available for KMED over this range.
HOLDINGS
TOP 1 OF 1 · 0.00% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
